Gravcef S 250mg/125mg Injection
Marketer
Gravion Life Sciences
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Gravcef S 250mg/125mg Injection
Cefuroxime and Sulbactam injection (250mg/125mg), a dual-action antibiotic, combats diverse bacterial infections. Its mechanism halts microbial proliferation, controlling infection spread. Administration must be overseen by a physician. Adhere strictly to the prescribed dosage schedule; complete the full course, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical consultation. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt emergency attention. Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals require physician approval. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration promote optimal recovery. Laboratory monitoring may be utilized to assess treatment effectiveness.
Uses of Gravcef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Gravcef S 250mg/125mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Gravcef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Gravcef S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Gravcef S 250mg/125mg Injection works:
The injectable formulation Gravcef S, containing 250mg Ceftriaxone and 125mg Sulbactam, unites an antibiotic with a resistance modifier. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial defenses, thereby augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
The concomitant use of alcohol and Gravcef S 250mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Gravcef S (250mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Gravcef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Gravcef S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Gravcef S 250mg/125mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable formulation Gravcef S (250mg/125mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Gravcef S (250mg/125mg) injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Gravcef S 250mg/125mg Injection :
Omit a dose of Gravcef S 250mg/125mg Injection? Seek medical advice immediately.
Facts to Know About Gravcef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently